Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands

Haiya Wu, Karima Mezghenna, Patricia Marmol, Tingqing Guo, Annalena Moliner, Shao Nian Yang, Per Olof Berggren, Carlos F. Ibáñez

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aims/hypothesis: Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells is regulated by paracrine factors, the identity and mechanisms of action of which are incompletely understood. Activins are expressed in pancreatic islets and have been implicated in the regulation of GSIS. Activins A and B signal through a common set of intracellular components, but it is unclear whether they display similar or distinct functions in glucose homeostasis. Methods: We examined glucose homeostatic responses in mice lacking activin B and in pancreatic islets derived from these mutants. We compared the ability of activins A and B to regulate downstream signalling, ATP production and GSIS in islets and beta cells. Results: Mice lacking activin B displayed elevated serum insulin levels and GSIS. Injection of a soluble activin B antagonist phenocopied these changes in wild-type mice. Isolated pancreatic islets from mutant mice showed enhanced GSIS, which could be rescued by exogenous activin B. Activin B negatively regulated GSIS and ATP production in wild-type islets, while activin A displayed the opposite effects. The downstream mediator Smad3 responded preferentially to activin B in pancreatic islets and beta cells, while Smad2 showed a preference for activin A, indicating distinct signalling effects of the two activins. In line with this, overexpression of Smad3, but not Smad2, decreased GSIS in pancreatic islets. Conclusions/ interpretation: These results reveal a tug-of-war between activin ligands in the regulation of insulin secretion by beta cells, and suggest that manipulation of activin signalling could be a useful strategy for the control of glucose homeostasis in diabetes and metabolic disease.

Original languageEnglish
Pages (from-to)148-156
Number of pages9
JournalDiabetologia
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Smad Proteins
Activins
Islets of Langerhans
Insulin
Ligands
Glucose
Insulin-Secreting Cells
Homeostasis
Adenosine Triphosphate
activin B
Metabolic Diseases

Keywords

  • ALK7
  • ATP
  • GSIS
  • Insulin secretion
  • Islet
  • Mitochondria
  • Smad
  • TGF-β

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Wu, H., Mezghenna, K., Marmol, P., Guo, T., Moliner, A., Yang, S. N., ... Ibáñez, C. F. (2014). Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands. Diabetologia, 57(1), 148-156. https://doi.org/10.1007/s00125-013-3079-6

Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands. / Wu, Haiya; Mezghenna, Karima; Marmol, Patricia; Guo, Tingqing; Moliner, Annalena; Yang, Shao Nian; Berggren, Per Olof; Ibáñez, Carlos F.

In: Diabetologia, Vol. 57, No. 1, 01.01.2014, p. 148-156.

Research output: Contribution to journalArticle

Wu, H, Mezghenna, K, Marmol, P, Guo, T, Moliner, A, Yang, SN, Berggren, PO & Ibáñez, CF 2014, 'Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands', Diabetologia, vol. 57, no. 1, pp. 148-156. https://doi.org/10.1007/s00125-013-3079-6
Wu, Haiya ; Mezghenna, Karima ; Marmol, Patricia ; Guo, Tingqing ; Moliner, Annalena ; Yang, Shao Nian ; Berggren, Per Olof ; Ibáñez, Carlos F. / Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands. In: Diabetologia. 2014 ; Vol. 57, No. 1. pp. 148-156.
@article{8a4cb6edd53e42feaecbf8d45c1aeb1d,
title = "Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands",
abstract = "Aims/hypothesis: Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells is regulated by paracrine factors, the identity and mechanisms of action of which are incompletely understood. Activins are expressed in pancreatic islets and have been implicated in the regulation of GSIS. Activins A and B signal through a common set of intracellular components, but it is unclear whether they display similar or distinct functions in glucose homeostasis. Methods: We examined glucose homeostatic responses in mice lacking activin B and in pancreatic islets derived from these mutants. We compared the ability of activins A and B to regulate downstream signalling, ATP production and GSIS in islets and beta cells. Results: Mice lacking activin B displayed elevated serum insulin levels and GSIS. Injection of a soluble activin B antagonist phenocopied these changes in wild-type mice. Isolated pancreatic islets from mutant mice showed enhanced GSIS, which could be rescued by exogenous activin B. Activin B negatively regulated GSIS and ATP production in wild-type islets, while activin A displayed the opposite effects. The downstream mediator Smad3 responded preferentially to activin B in pancreatic islets and beta cells, while Smad2 showed a preference for activin A, indicating distinct signalling effects of the two activins. In line with this, overexpression of Smad3, but not Smad2, decreased GSIS in pancreatic islets. Conclusions/ interpretation: These results reveal a tug-of-war between activin ligands in the regulation of insulin secretion by beta cells, and suggest that manipulation of activin signalling could be a useful strategy for the control of glucose homeostasis in diabetes and metabolic disease.",
keywords = "ALK7, ATP, GSIS, Insulin secretion, Islet, Mitochondria, Smad, TGF-β",
author = "Haiya Wu and Karima Mezghenna and Patricia Marmol and Tingqing Guo and Annalena Moliner and Yang, {Shao Nian} and Berggren, {Per Olof} and Ib{\'a}{\~n}ez, {Carlos F.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00125-013-3079-6",
language = "English",
volume = "57",
pages = "148--156",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands

AU - Wu, Haiya

AU - Mezghenna, Karima

AU - Marmol, Patricia

AU - Guo, Tingqing

AU - Moliner, Annalena

AU - Yang, Shao Nian

AU - Berggren, Per Olof

AU - Ibáñez, Carlos F.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aims/hypothesis: Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells is regulated by paracrine factors, the identity and mechanisms of action of which are incompletely understood. Activins are expressed in pancreatic islets and have been implicated in the regulation of GSIS. Activins A and B signal through a common set of intracellular components, but it is unclear whether they display similar or distinct functions in glucose homeostasis. Methods: We examined glucose homeostatic responses in mice lacking activin B and in pancreatic islets derived from these mutants. We compared the ability of activins A and B to regulate downstream signalling, ATP production and GSIS in islets and beta cells. Results: Mice lacking activin B displayed elevated serum insulin levels and GSIS. Injection of a soluble activin B antagonist phenocopied these changes in wild-type mice. Isolated pancreatic islets from mutant mice showed enhanced GSIS, which could be rescued by exogenous activin B. Activin B negatively regulated GSIS and ATP production in wild-type islets, while activin A displayed the opposite effects. The downstream mediator Smad3 responded preferentially to activin B in pancreatic islets and beta cells, while Smad2 showed a preference for activin A, indicating distinct signalling effects of the two activins. In line with this, overexpression of Smad3, but not Smad2, decreased GSIS in pancreatic islets. Conclusions/ interpretation: These results reveal a tug-of-war between activin ligands in the regulation of insulin secretion by beta cells, and suggest that manipulation of activin signalling could be a useful strategy for the control of glucose homeostasis in diabetes and metabolic disease.

AB - Aims/hypothesis: Glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells is regulated by paracrine factors, the identity and mechanisms of action of which are incompletely understood. Activins are expressed in pancreatic islets and have been implicated in the regulation of GSIS. Activins A and B signal through a common set of intracellular components, but it is unclear whether they display similar or distinct functions in glucose homeostasis. Methods: We examined glucose homeostatic responses in mice lacking activin B and in pancreatic islets derived from these mutants. We compared the ability of activins A and B to regulate downstream signalling, ATP production and GSIS in islets and beta cells. Results: Mice lacking activin B displayed elevated serum insulin levels and GSIS. Injection of a soluble activin B antagonist phenocopied these changes in wild-type mice. Isolated pancreatic islets from mutant mice showed enhanced GSIS, which could be rescued by exogenous activin B. Activin B negatively regulated GSIS and ATP production in wild-type islets, while activin A displayed the opposite effects. The downstream mediator Smad3 responded preferentially to activin B in pancreatic islets and beta cells, while Smad2 showed a preference for activin A, indicating distinct signalling effects of the two activins. In line with this, overexpression of Smad3, but not Smad2, decreased GSIS in pancreatic islets. Conclusions/ interpretation: These results reveal a tug-of-war between activin ligands in the regulation of insulin secretion by beta cells, and suggest that manipulation of activin signalling could be a useful strategy for the control of glucose homeostasis in diabetes and metabolic disease.

KW - ALK7

KW - ATP

KW - GSIS

KW - Insulin secretion

KW - Islet

KW - Mitochondria

KW - Smad

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=84890903747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890903747&partnerID=8YFLogxK

U2 - 10.1007/s00125-013-3079-6

DO - 10.1007/s00125-013-3079-6

M3 - Article

VL - 57

SP - 148

EP - 156

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 1

ER -